List of Bulk Drug Substances for Compounding Office Stock Drugs for Use in Nonfood-Producing Animals or Antidotes for Food-Producing Animals; Request for Nominations

An individual argues that certain medications need to be included in the list of bulk drug substances for compounding to ensure pets receive correct dosages and affordable treatment options. They emphasize that veterinary clinics require immediate access to these medications for urgent care, which is not feasible if they cannot keep them in stock.

A feline exclusive veterinarian opposes the FDA's actions regarding compounded drugs, arguing that they are critical for providing immediate and appropriate care to patients. The commenter highlights specific medications where commercial alternatives are either unavailable, toxic, or provide incorrect dosages for small animals.

A veterinary hospital owner argues against limiting the compounding of Enrofloxacin and Doxycycline for hospital use. They state that the current restrictions make it difficult to treat small exotic pets (like reptiles and birds) because standard high-concentration medications are unsafe for their weight, and ordering individual compounded prescriptions takes too long for critically ill patients.

A veterinary professional argues that compounding is essential for providing tailored medications to animals, especially when commercial products are not feasible due to size, allergies, or patient compliance issues. The commenter requests that specific medications commonly used in small animal hospitals be considered for the list of bulk drug substances for compounding.

A board-certified veterinary dentist is requesting the inclusion of doxycycline suspension on the list of bulk drug substances for compounding. The commenter argues that the liquid form is necessary to provide lower concentrations (as low as 10 mg) that are not available in tablet form and are safer for cats with specific health conditions.

A veterinary professional requests that Doxycycline, Metronidazole, and buprenorphine be added to the list of bulk drug substances for compounding office stock for companion animals. The commenter argues that standard manufactured sizes do not meet diverse weight requirements and that compounded multi-dose vials are necessary to overcome delivery delays and administration difficulties.

A veterinary professional (implied by the mention of "patients" and "owners") argues in favor of keeping Doxycycline on the list of bulk drug substances for compounding. They state that having it available as a compounded, flavored medication improves patient compliance and allows for immediate treatment.

A veterinary professional argues that allowing compounded doxycycline suspensions to be kept in office stock is essential for patient care. They state that commercial options often require impractical dosing amounts and that compounded versions improve palatability and owner compliance.